RP Group (n = 35) | IP Group (n = 72) | IP/RP Group (n = 72) | p | |
---|---|---|---|---|
Age (median, range) | 50 (18-74) | 54 (28-78) | 54 (27-77) | 0.18 |
Menopausal Status (n, %) | 0.23 | |||
Premenopausal | 18 (51.4) | 25 (34.7) | 27 (37.5) | |
Postmenopausal | 17 (48.6) | 47 (65.3) | 45 (62.5) | |
Histology (n, %) | 0.42 | |||
Endometrioid | 12 (34.3) | 23 (31.9) | 17 (23.6) | |
Clear-cell | 10 (28.6) | 15 (20.8) | 23 (31.9) | |
Mucinous | 10 (28.6) | 24 (33.3) | 13 (18.1) | |
Mixed | 3 (8.6) | 10 (13.9) | 19 (26.4) | |
Gradea (n, %) | 0.078 | |||
1 | 5 (20) | 8 (14) | 6 (12.2) | |
2 | 9 (36) | 26 (45.6) | 10 (20.4) | |
3 | 11 (44) | 23(40.4) | 3 (67.3) | |
Baseline Serum CA 125 (u/mL) (median, range) | 118 (10-3305) | 200 (11-9523) | 400 (10-11,779) | 0.001 b |
Tumor size (cm) (median, range) | 12 (4-30) | 10 (3-39) | 10 (3-40) | 0.27 |
Ascites (n, %) | 0.001 b | |||
Yes | 12 (34.3) | 37 (51.4) | 51 (70.8) | |
No | 23 (65.7) | 35 (48.6) | 21 (29.2) | |
Peritoneal cytology (n, %) | < 0.001 b | |||
Positive | 12 (34.3) | 53 (73.6) | 53 (73.6) | |
Negative | 23 (65.7) | 19 (26.4) | 19 (26.4) | |
Bilaterality | 0.002 b | |||
Yes | 10 (28.6) | 28 (38.9) | 44 (61.1) | |
No | 25 (71.4) | 44 (61.1) | 28 (38.9) | |
Total number of LNs removed (median, range) | 43 (15-105) | 37.5 (15-93) | 40 (15-103) | 0.71 |
Number of pelvic LNs removed (median, range) | 25 (10-93) | 28.5 (10-75) | 28.5 (10-71) | 0.97 |
Number of para-aortic LNs removed (median, range) | 11 (5-46) | 8.5 (5-45) | 10 (5-54) | 0.57 |
CRS | 0.009 | |||
Optimal | 17 (48.6) | 17(30.9) | 17(30.9) | |
Maximal | 18 (51.4) | 55(69.1) | 55(69.1) |